NTX-1024

N/A

Report date: 2026/03/03 15:56:14
NME

Base Information

Drug NameNTX-1024
Drug Alias NameNTX-1024
ClassificationSmall molecules
Mechanisms of ActionGlycosaminoglycan Replacement
TargetsGlycosaminoglycan
Therapy Area/IndicationsKeratoconjunctivitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMexico
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNexEos Bio
China Registration ClassN/A

Develop Information

Active CompaniesNexEos Bio
Inactive CompaniesN/A
Active IndicationsKeratoconjunctivitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A